Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories

Artikel in diesem Heft

1. Frontmatter
2. Editorials
3. Targeting errors in microbiology: the case of the Gram stain
4. Time for a holistic approach and standardization education in laboratory medicine
5. Reviews
6. Serum uric acid levels and risk of prehypertension: a meta-analysis
7. Lactic acidosis: an update
8. Mini Review
9. Progress and impact of enzyme measurement standardization
10. Opinion Paper
11. Critical comments to a recent EFLM recommendation for the review of reference intervals
12. IFCC Paper
13. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
14. Genetics and Molecular Diagnostics
15. Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy
16. General Clinical Chemistry and Laboratory Medicine
17. Risk analysis of the preanalytical process based on quality indicators data
18. Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose?
19. Looking beyond linear regression and Bland-Altman plots: a comparison of the clinical performance of 25-hydroxyvitamin D tests
20. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience
21. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS
22. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
23. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
24. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
25. Cancer Diagnostics
26. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma
27. Cardiovascular Diseases
28. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
29. Infectious Diseases
30. Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology
31. Diabetes
32. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA_1c in diabetes patients
33. Corrigendum
34. EFLM Recommendation
35. Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories
36. Letters to the Editor
37. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
38. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators
39. Mixing studies for abnormal coagulation screen – the current trend
40. Identification of 5-fluorocytosine as a new interfering compound in serum capillary zone electrophoresis
41. How to define reference intervals to rule in healthy individuals for clinical trials?
42. Evaluation of the performance of INDEXOR^® in the archive unit of a clinical laboratory: a step to Lean laboratory
43. Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome
44. Analysis of hemolysis, icterus and lipemia in arterial blood gas specimens
45. Comparison of three routine insulin immunoassays: implications for assessment of insulin sensitivity and response